JOURNAL OF DERMATOLOGICAL TREATMENT Journal
Overview
publication venue for
- Cardiometabolic multimorbidity is common among patients with psoriasis and is associated with poorer outcomes compared to those without comorbidity 2022
- Clinical implications and predictive values of early PASI responses to tildrakizumab in patients with moderate-to-severe plaque psoriasis 2021
- Physical activity engagement and responses to exercise in plaque psoriasis: a multifactorial investigation of influential factors 2020
- Characterization of Insufficient Responders to Ustekinumab in Patients With Moderate-to-Severe Psoriasis in the US Corrona Psoriasis Registry. 2020
- Psoriasis in solid organ transplant patients: best practice recommendations from The Medical Board of the National Psoriasis Foundation. 29:329-333. 2018
- Early development and qualitative evidence of content validity for the Psoriasis Symptom Inventory (PSI), a patient-reported outcome measure of psoriasis symptom severity. 24:255-260. 2013
- A case of non‐Hodgkin's lymphoma‐associated pemphigus foliaceus and use of rituximab for treatment. 19:368-370. 2008
- Risk of herpes zoster with IL-17 inhibitor therapy for psoriasis and other inflammatory conditions 2020
Research
category
- DERMATOLOGY Web of Science Category
Identity
International Standard Serial Number (ISSN)
- 0954-6634
Electronic International Standard Serial Number (EISSN)
- 1471-1753
Other
journal abbreviation
- J DERMATOL TREAT